Jackson ImmunoResearch Europe Ltd (JIR-E) was started in 2004 as a product distribution center to provide European scientists with a direct link to the manufacturer, Jackson ImmunoResearch Laboratories, Inc.(JIR), for direct purchases and technical service.  Direct orders may be placed from Austria, Belgium, Bosnia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lebanon, Lithuania, Luxemburg, Macedonia, The Netherlands, Norway, Poland, Portugal, Russia, Slovenia, Sweden, Spain, Switzerland, and Turkey.

JIR ships daily from the USA to JIR-E, located near London in the UK. This provides minimal turn around time between placing an order and receiving products. We now have an inventory of popular items at JIR-E for even faster turn around times.  Products may be ordered from JIR-E by email, fax, mail, telephone, or by credit card using the secure on-line shopping cart in this Web site.

Other advantages to European scientists include automatic volume discounts and prices which are lower than those offered by local distributors, complete product line availability, fewer import problems, payments in Euros, and direct technical service from JIR-trained product specialists.

The parent company, Jackson ImmunoResearch Laboratories, Inc., specialises in the production and conjugation of affinity-purified, secondary antibodies and purified immunoglobulins.  Our products are sold primarily to scientists in universities and research institutes throughout the world who are conducting research in the plant, animal, and biomedical sciences.

The company was started in 1982 by research scientists whose education and previous experience included research in cell biology, protein chemistry, and microbiology, and product development in immunology. Our goal is to provide other scientists with the newest, largest selection of, and highest quality of secondary reagents, with the best technical and customer services possible. The products are for research use only, and not for diagnostics or therapeutics. They are not primary antibodies, nor are they medical devices.

We hope this site will provide not only information about our company and our products, but also answer some technical questions about common problems you may have regarding the use of our reagents. Please let us know if you have any suggestions about how we might reach these goals more effectively or about other information you would like to see presented here.

Sue Hallett, BSc (hons)
Managing Director
Jackson ImmunoResearch Europe, Ltd

William Jackson Stegeman, Ph.D.
President and CEO
Jackson ImmunoResearch Laboratories, Inc.
Jackson ImmunoResearch Europe, Ltd